“…The multi-institutional study on HIVassociated prostate cancer reported by Pantanowitz et al [1] is a timely reminder of the concerns about cancer in patients with HIV in the era of highly active antiretroviral therapy (HAART). Although the authors provide a valuable case series and insight into the debate on the increasing incidence of prostate cancer in patients with HIV, they fail to discuss some important aspects of hormone therapy pertinent to the modern patient with HIV which we have identified through our multi-disciplinary experience from our institution.…”